Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: A potential role in connective tissue destruction
- 26 April 2007
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 212 (1) , 189-194
Abstract
Fibroblasts, a major constituent of gingival connective tissue, can produce immunoregulatory cytokines and proteolytic enzymes that may contribute to tissue destruction. In this study, we evaluated the production of matrix metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs), and plasminogen activators by gingival fibroblasts stimulated with lipopolysaccharides (LPS) produced by periodontopathogens, including Actinobacillus actinomycetemcomitans. In addition, changes in the expression and phosphorylation state of fibroblast intracellular signaling proteins induced by A. actinomycetemcomitans LPS were characterized using antibody microarrays. We showed that A. actinomycetemcomitans LPS induced the production of a 50 kDa plasminogen activator, MMP‐2 and, to a lesser extent, MMP‐3 by fibroblasts. The stimulation of fibroblasts with A. actinomycetemcomitans LPS also resulted in the overproduction of TIMP‐1, but had no effect on the production of TIMP‐2. Comparable responses were also obtained with Porphyromonas gingivalis and Fusobacterium nucleatum subsp. nucleatum LPS. The results of the microarray analyses showed that A. actinomycetemcomitans LPS induced changes in the phosphorylation state and expression of gingival fibroblast intracellular signaling proteins. More specifically, they suggested that A. actinomycetemcomitans LPS may induce both Jun N‐terminus protein‐serine kinases (JNK) and mitogen‐activated protein‐serine kinase p38 alpha (p38α MAPK) pathway activation, leading to increased activator protein‐1 (AP‐1) and nuclear factor kappa‐B (NFκB) activities, which in turn can stimulate MMP‐2, MMP‐3, TIMP‐1, and urokinase‐type plasminogen activator (uPA) expression. This may contribute to periodontal connective tissue destruction. J. Cell. Physiol. 212: 189–194, 2007.Keywords
This publication has 46 references indexed in Scilit:
- TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoGenes & Development, 2005
- Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitorsLife Sciences, 2004
- A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersBiochemical Journal, 2003
- Role of Nuclear Factor-κB Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Cathepsin C, Matrix Metalloproteinases, and their Tissue Inhibitors in Gingiva and Gingival Crevicular Fluid from Periodontitis-affected PatientsJournal of Dental Research, 2002
- Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelAOncogene, 1999
- Effect of Campylobacter rectus LPS on plasminogen activator‐plasmin system in human gingival fibroblast cellsJournal of Periodontal Research, 1995
- Role of Matrix Metalloproteinases in Human Periodontal Diseases*Journal of Periodontology, 1993
- Role of Matrix Metalloproteinases in Human Periodontal DiseasesJournal of Periodontology, 1993
- Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseasesJournal of Clinical Periodontology, 1988